These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27190750)

  • 1. Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma.
    Hu HJ; Mao H; Tan YQ; Shrestha A; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    Springerplus; 2016; 5():551. PubMed ID: 27190750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of preoperative CA19-9 levels in evaluating resectability of gallbladder carcinoma.
    Liu F; Wang JK; Ma WJ; Yang Q; Hu HJ; Li FY
    ANZ J Surg; 2019 Mar; 89(3):E76-E80. PubMed ID: 30306702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma.
    Fang T; Wang H; Wang Y; Lin X; Cui Y; Wang Z
    Dis Markers; 2019; 2019():6016931. PubMed ID: 30863466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma.
    Hu HJ; Jin YW; Zhou RX; Ma WJ; Yang Q; Wang JK; Liu F; Cheng NS; Li FY
    J Gastrointest Surg; 2019 Mar; 23(3):510-517. PubMed ID: 30076591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
    Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
    J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma].
    Zong D; Zeng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):819-22. PubMed ID: 25341348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer.
    Kiliç M; Göçmen E; Tez M; Ertan T; Keskek M; Koç M
    Can J Surg; 2006 Aug; 49(4):241-4. PubMed ID: 16948881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of a pre-operative radiological scoring system in determining resectability for potentially resectable hilar cholangiocarcinoma.
    Bird N; McKenna A; Dunne D; Francis B; Fenwick S; Poston G; Jones R; Malik H
    Eur J Surg Oncol; 2019 Feb; 45(2):192-197. PubMed ID: 30297275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis.
    Benke M; Farkas N; Hegyi P; Tinusz B; Sarlós P; Erőss B; Szemes K; Vörhendi N; Szakács Z; Szücs Á
    Pathol Oncol Res; 2022; 28():1610266. PubMed ID: 35645620
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder.
    Agrawal S; Gupta A; Gupta S; Goyal B; Siddeek RAT; Rajput D; Chauhan U; Kishore S; Gupta M; Kant R
    J Carcinog; 2020; 19():4. PubMed ID: 33033460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria.
    Lee HY; Kim SH; Lee JM; Kim SW; Jang JY; Han JK; Choi BI
    Radiology; 2006 Apr; 239(1):113-21. PubMed ID: 16467211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDCT assessment of resectability in hilar cholangiocarcinoma.
    Ni Q; Wang H; Zhang Y; Qian L; Chi J; Liang X; Chen T; Wang J
    Abdom Radiol (NY); 2017 Mar; 42(3):851-860. PubMed ID: 27770159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9.
    Lundin J; Roberts PJ; Kuusela P; Haglund C
    Anticancer Res; 1995; 15(5B):2181-6. PubMed ID: 8572621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma.
    Maithel SK; Maloney S; Winston C; Gönen M; D'Angelica MI; Dematteo RP; Jarnagin WR; Brennan MF; Allen PJ
    Ann Surg Oncol; 2008 Dec; 15(12):3512-20. PubMed ID: 18781364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.
    Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K
    J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.